Thomas Butler

Person

Redwood City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of menin-MLL interaction
- Patent number 12,275,739
- Issue date Apr 15, 2025
- BIOMEA FUSION, INC.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent inhibitors of menin-MLL interaction for diabetes mellitus
- Patent number 12,251,385
- Issue date Mar 18, 2025
- BIOMEA FUSION, INC.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyridines as irreversible inhibitors of menin-MLL inter...
- Patent number 12,116,371
- Issue date Oct 15, 2024
- BIOMEA FUSION, INC.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Irreversible inhibitors of menin-MLL interaction
- Patent number 12,077,544
- Issue date Sep 3, 2024
- BIOMEA FUSION, INC.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrim...
- Patent number 12,018,032
- Issue date Jun 25, 2024
- BIOMEA FUSION, INC.
- Priyanka Somanath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazine compounds as inhibitors of FLT3
- Patent number 11,945,785
- Issue date Apr 2, 2024
- BIOMEA FUSION, INC.
- David Sperandio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of menin-mll interaction
- Patent number 11,845,753
- Issue date Dec 19, 2023
- BIOMEA FUSION, INC.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyridines as irreversible inhibitors of menin-MLL inter...
- Patent number 11,702,421
- Issue date Jul 18, 2023
- BIOMEA FUSION, LLC
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of menin-MLL interaction
- Patent number 11,174,263
- Issue date Nov 16, 2021
- BIOMEA FUSION, INC.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyridines as irreversible inhibitors of menin-MLL inter...
- Patent number 11,084,825
- Issue date Aug 10, 2021
- BIOMEA FUSION, LLC
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes and intermediates for the preparation of 1′-substituted c...
- Patent number 10,988,498
- Issue date Apr 27, 2021
- Gilead Sciences, Inc.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes and intermediates for the preparation of 1′-substituted c...
- Patent number 10,023,600
- Issue date Jul 17, 2018
- Gilead Sciences, Inc.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1′-substituted carba-nucleoside analogs for antiviral treatment
- Patent number RE46762
- Issue date Mar 27, 2018
- Gilead Sciences, Inc.
- Thomas Butler
Information Patent Grant
1′-substituted carba-nucleoside analogs for antiviral treatment
- Patent number 8,853,171
- Issue date Oct 7, 2014
- Gilead Sciences, Inc.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1′substituted carba-nucleoside analogs for antiviral treatment
- Patent number 8,318,682
- Issue date Nov 27, 2012
- Gilead Sciences, Inc.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carba-nucleoside analogs for antiviral treatment
- Patent number 8,012,942
- Issue date Sep 6, 2011
- Gilead Sciences, Inc.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1′-substituted carba-nucleoside analogs for antiviral treatment
- Patent number 8,008,264
- Issue date Aug 30, 2011
- Gilead Sciences, Inc.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRAZINE COMPOUNDS AS IRREVERSIBLE INHIBITORS OF FLT3
- Publication number 20250136558
- Publication date May 1, 2025
- BIOMEA FUSION, INC.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS
- Publication number 20250066386
- Publication date Feb 27, 2025
- BIOMEA FUSION, INC.
- Thorsten A. Kirschberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IRREVERSIBLE INHIBITORS OF KRAS
- Publication number 20240409558
- Publication date Dec 12, 2024
- BIOMEA FUSION, INC.
- Yongli Su
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[...
- Publication number 20240376112
- Publication date Nov 14, 2024
- BIOMEA FUSION, INC.
- Thomas BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF AN IRREVERSIBLE INHIBITOR OF MENIN-MLL INTERAC...
- Publication number 20240343731
- Publication date Oct 17, 2024
- BIOMEA FUSION, INC.
- Priyanka SOMANATH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZINE COMPOUNDS AS INHIBITORS OF FLT3
- Publication number 20240262795
- Publication date Aug 8, 2024
- BIOMEA FUSION, INC.
- David Sperandio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF MENIN-MLL INTERACTION
- Publication number 20240140953
- Publication date May 2, 2024
- BIOMEA FUSION, INC.
- Thomas BUTLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF MENIN-MLL INTERACTION
- Publication number 20240124467
- Publication date Apr 18, 2024
- BIOMEA FUSION, INC.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION
- Publication number 20230391784
- Publication date Dec 7, 2023
- BIOMEA FUSION, INC.
- Thomas BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINE COMPOUNDS AS INHIBITORS OF FLT3
- Publication number 20230339867
- Publication date Oct 26, 2023
- BIOMEA FUSION, INC.
- David Sperandio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION
- Publication number 20230227458
- Publication date Jul 20, 2023
- BIOMEA FUSION, INC.
- Thomas BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COVALENT INHIBITORS OF MENIN-MLL INTERACTION FOR DIABETES MELLITUS
- Publication number 20230120115
- Publication date Apr 20, 2023
- BIOMEA FUSION, INC.
- Thomas BUTLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF AN IRREVERSIBLE INHIBITOR OF MENIN-MLL INTERAC...
- Publication number 20230086137
- Publication date Mar 23, 2023
- BIOMEA FUSION, INC.
- Priaynka SOMANATH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION
- Publication number 20220169627
- Publication date Jun 2, 2022
- BIOMEA FUSION, LLC
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF MENIN-MLL INTERACTION
- Publication number 20220024936
- Publication date Jan 27, 2022
- BIOMEA FUSION, INC.
- Thomas BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1`-SUBSTITUTED C...
- Publication number 20210403497
- Publication date Dec 30, 2021
- GILEAD SCIENCES, INC.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF MENIN-MLL INTERACTION
- Publication number 20200255434
- Publication date Aug 13, 2020
- Biomea Fusion, LLC
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION
- Publication number 20200223853
- Publication date Jul 16, 2020
- Biomea Fusion, LLC
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1'-SUBSTITUTED C...
- Publication number 20180327437
- Publication date Nov 15, 2018
- GILEAD SCIENCES, INC.
- Thomas Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
- Publication number 20130344028
- Publication date Dec 26, 2013
- Thomas BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
- Publication number 20130034521
- Publication date Feb 7, 2013
- GILEAD SCIENCES, INC.
- Thomas BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1'SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
- Publication number 20110293563
- Publication date Dec 1, 2011
- GILEAD SCIENCES, INC.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1'-SUBSTITUTED C...
- Publication number 20110230654
- Publication date Sep 22, 2011
- GILEAD SCIENCES, INC.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
- Publication number 20100203015
- Publication date Aug 12, 2010
- GILEAD SCIENCES, INC.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
- Publication number 20100021425
- Publication date Jan 28, 2010
- GILEAD SCIENCES, INC.
- Thomas Butler
- C07 - ORGANIC CHEMISTRY

Thomas Butler

Person

Patents Grantslast 30 patents

Inhibitors of menin-MLL interaction

Covalent inhibitors of menin-MLL interaction for diabetes mellitus

Substituted pyridines as irreversible inhibitors of menin-MLL inter...

Irreversible inhibitors of menin-MLL interaction

Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrim...

Pyrazine compounds as inhibitors of FLT3

Inhibitors of menin-mll interaction

Substituted pyridines as irreversible inhibitors of menin-MLL inter...

Inhibitors of menin-MLL interaction

Substituted pyridines as irreversible inhibitors of menin-MLL inter...

Processes and intermediates for the preparation of 1′-substituted c...

Processes and intermediates for the preparation of 1′-substituted c...

1′-substituted carba-nucleoside analogs for antiviral treatment

1′-substituted carba-nucleoside analogs for antiviral treatment

1′substituted carba-nucleoside analogs for antiviral treatment

Carba-nucleoside analogs for antiviral treatment

1′-substituted carba-nucleoside analogs for antiviral treatment

Patents Applicationslast 30 patents

PYRAZINE COMPOUNDS AS IRREVERSIBLE INHIBITORS OF FLT3

INHIBITORS OF KRAS

IRREVERSIBLE INHIBITORS OF KRAS

N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[...

CRYSTALLINE FORMS OF AN IRREVERSIBLE INHIBITOR OF MENIN-MLL INTERAC...

PYRAZINE COMPOUNDS AS INHIBITORS OF FLT3

INHIBITORS OF MENIN-MLL INTERACTION

FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF MENIN-MLL INTERACTION

IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION

PYRAZINE COMPOUNDS AS INHIBITORS OF FLT3

IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION

COVALENT INHIBITORS OF MENIN-MLL INTERACTION FOR DIABETES MELLITUS

CRYSTALLINE FORMS OF AN IRREVERSIBLE INHIBITOR OF MENIN-MLL INTERAC...

IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION

INHIBITORS OF MENIN-MLL INTERACTION

PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1`-SUBSTITUTED C...

INHIBITORS OF MENIN-MLL INTERACTION

IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION

PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1'-SUBSTITUTED C...

1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

1'SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1'-SUBSTITUTED C...

CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT